Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha

22Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Zerumbone is a known anti-cancer herbal compound. However, the actual protein target is not fully understood or known. This investigation focus on the association of zerumbone in HCT116 colon cancer cell proliferation and its link with TNF-alpha. The study shows that with the increasing concentration of zerumbone, there was a reduction of HCT116 cells proliferation based on the cell line study and hence higher TNF-alpha inhibition based on the TNF-alpha assay. The study also emphasizes on the computational aspect by investigating the molecular docking analysis of zerumbone against TNF-alpha. The docked complex was further validated using molecular dynamics simulation studies. The docking analysis observed that alpha-beta unsaturated carbonyl scaffold is an important moiety for the anti-cancer activity of zerumbone. Furthermore, the DFT analysis also confirms the reactivity nature of zerumbone based on the frontier molecular orbital analysis.

Cite

CITATION STYLE

APA

Singh, S. P., Nongalleima, K., Singh, N. I., Doley, P., Singh, C. B., Singh, T. R., & Sahoo, D. (2018). Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha. Scientific Reports, 8(1). https://doi.org/10.1038/s41598-018-22362-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free